News

Article

The impact of additional IPL sessions on MGD management

Author(s):

Authors reported that increasing the number of intense pulsed light (IPL) sessions is beneficial for patients with moderate-to-severe meibomian gland dysfunction (MGD) to increase the response rate of treatment.

(Image Credit: AdobeStock/Viacheslav Yakobchuk)

(Image Credit: AdobeStock/Viacheslav Yakobchuk)

Yang Lu, MD, first author, and colleagues from the Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, and the NHC Key Laboratory of Myopia, Fudan University, both in Shanghai, China, reported that increasing the number of intense pulsed light (IPL) sessions is beneficial for patients with moderate-to-severe meibomian gland dysfunction (MGD) to increase the response rate of treatment.1

The clinicians conducted this retrospective study to determine if 90 Asian adult patients with moderate–to–severe MGD could benefit from increasing the number of IPL treatment sessions. Moderate-to-severe MGD is classified as stages 3 to 4.

The patients were divided into 2 groups: 30 patients in group 1 underwent 5 sessions of IPL and 63.3% of them also had expression of the meibomian glands, and 60 patients in group 2 underwent 3 sessions of IPL and 60% also underwent meibomian gland expression.

Results of group comparison

The investigators found that in both groups the symptoms and most clinical indices improved after the IPL treatment sessions finished.

They did not observe a statistical difference in any of the improvement levels of all symptomatic and physical indices, including the ocular surface disease index, tear film break–up time, Demodex, corneal staining, meibum quality, meibomian gland expressibility, and MGD stage (p ≥ 0.05 for all comparisons) between the 2 groups at any time, that is month by month and at the final visit.

However, the investigators did see that the response rate in group 1 after the 5 session of IPL increased compared to the patients in group 2 who were treated with 3 session of IPL treatment (70.0% vs. 63.33%, respectively).

The authors commented, “Increasing the number of IPL sessions is beneficial for patients with moderate-to-severe MGD to increase the response rate of treatment rather than the improvement level. However, there is no need for patients who respond well to a routine number of IPL treatments to undergo additional IPL sessions.”

Reference:
  1. Lu Y, Gong L, Yin Y. Need to increase the number of intense pulsed light (IPL) treatment sessions for patients with moderate to severe meibomian gland dysfunction (MGD). Curr Eye Res. 2024;49:362–367; https://doi.org/10.1080/02713683.2023.2297344

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.